Key Highlights Motixafortide effectively mobilized sufficient hematopoietic stem cells (HSCs) in patients with sickle cell disease enabling accelerated access to gene therapies 90% (9 of 10) of ...
NEW YORK CITY, NEW YORK / ACCESS Newswire / December 5, 2025 / Every market moves on information. Sometimes that information arrives slowly. Sometimes it arrives all at once. The surge in attention ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results